Aqueous extract of Abutilon indicum Sweet inhibits glucose absorption and stimulates insulin secretion in rodents

Nutrition Research

Volumn 29, Issue 8, 2009, Pages 579-587

  Krisanapun, Chutwadee ^a   Peungvicha, Penchom ^a   Temsiririrkkul, Rungravi ^a   Wongkrajang, Yuvadee ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Abutilon indicum Sweet; Antidiabetic activity; Insulin secretion; Intestinal glucose absorption; Mouse; Oral glucose tolerance test; Rat; Rodent

Indexed keywords

ABUTILON INDICUM EXTRACT; ALKALOID; ANTIDIABETIC AGENT; FLAVONOID; GLIBENCLAMIDE; GLYCOSIDE; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; TANNIN DERIVATIVE; UNCLASSIFIED DRUG; WATER;

ABUTILON INDICUM; ANGIOSPERM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; GLUCOSE ABSORPTION; GLUCOSE BLOOD LEVEL; HYPOTHESIS; INSULIN RELEASE; INSULINOMA; INTESTINE ABSORPTION; MALE; MOUSE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT; RODENT; STREPTOZOCIN DIABETES; TUMOR CELL;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIETARY SUCROSE; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOSE; GLUCOSE TOLERANCE TEST; GLYBURIDE; HYPOGLYCEMIC AGENTS; INSULIN; INTESTINAL ABSORPTION; ISLETS OF LANGERHANS; MALE; MALVACEAE; MICE; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, WISTAR; REFERENCE VALUES;

ABUTILON INDICUM; RATTUS; RODENTIA;

EID: 70049090387     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nutres.2009.07.006     Document Type: Article

References (43)

1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 31 (2008) S55-S60
2. Wild S., Roglic G., Green A., Sicree R., and King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27 (2004) 1047-1053
3. American Diabetes Association. Standards of medical care in diabetes-2008. Diabetes Care 31 (2008) S12-S54
4. Harrigan R.A., Nathan M.S., and Beattie P. Oral agents for the treatment of type 2 diabetes mellitus: pharmacology, toxicity, and treatment. Ann Emerg Med 38 (2001) 68-78
5. Pari L., and Amarnath Satheesh M. Antidiabetic activity of Boerhaavia diffusa L: effect on hepatic key enzymes in experimental diabetes. J Ethnopharmacol 91 (2004) 109-113
6. Pari L., and Saravanan R. Antidiabetic effect of diasulin, a herbal drug, on blood glucose, plasma insulin and hepatic enzymes of glucose metabolism in hyperglycaemic rats. Diabetes Obes Metab 6 (2004) 286-292
7. Aekplakorn W., Stolk R.P., Neal B., Suriyawongpaisal P., Chongsuvivatwong V., Cheepudomwit S., et al. The prevalence and management of diabetes in Thai adults: the international collaborative study of cardiovascular disease in Asia. Diabetes Care 26 (2003) 2758-2763
8. Gray A.M., Abdel-Wahab Y.H., and Flatt P.R. The traditional plant treatment, Sambucus nigra (elder), exhibits insulin-like and insulin-releasing actions in vitro. J Nutr 130 (2000) 15-20
9. Odetola A.A., Akinloye O., Egunjobi C., Adekunle W.A., and Ayoola A.O. Possible antidiabetic and antihyperlipidaemic effect of fermented Parkia biglobosa (JACQ) extract in alloxan-induced diabetic rats. Clin Exp Pharmacol Physiol 33 (2006) 808-812
10. In: Jayaweera DMA. (Ed). Medicinal plants (Indigenous and Exotic) used in Ceylon. Part IV Magnoliaceae-Rubiaceae (1982), Columbo, The national science council of Sri Lanka 9
11. Thongsiri P. Anti-diabetic activity of Thai medicinal herbs in normal and streptozotocin-diabetic rats (M.S. thesis). Nakorn Pathom: Faculty of Graduate studies, Mahidol University, Thailand; 2001.
12. Seetharam Y.N., Chalageri G., and Setty S.R. Bheemachar. Hypoglycemic activity of Abutilon indicum leaf extracts in rats. Fitoterapia 73 (2002) 156-159
13. Porchezhian E., and Ansari S.H. Hepatoprotective activity of Abutilon indicum on experimental liver damage in rats. Phytomedicine 12 (2005) 62-64
14. Kishan A.R., Ajitha M., and Rajanarayana K. Antidiabetic, antihyperlipidemic and free radical scavenging activities of an Ayurvedic medicine. Indian Drugs 37 (2000) 130-132
15. Mitra S.K., Gopumadhavan S., Muralidhar T.S., Anturlikar S.D., and Sujatha M.B. Effect of a herbomineral preparation D-400 in streptozotocin-induced diabetic rats. J Ethnopharmacol 54 (1996) 41-46
16. Kohli K.R., Shilin G., and Kolhapure S.A. Evaluation of the clinical efficacy and safety of Diabecon in NIDDM. Antiseptic 101 (2004) 487-494
17. Parekh J., and Chanda S. Antibacterial and phytochemical studies on twelve species of Indian medicinal plants. Afr J Biomed Res 10 (2007) 175-181
18. Kumar V.P., Chauhan N.S., Padh H., and Rajani M. Search for antibacterial and antifungal agents from selected Indian medicinal plants. J Ethnopharmacol 107 (2006) 182-188
19. Chuakul W., Saralamp P., Paonil W., Temsiririrkkul R., and Clayton T. Medical plants in Thailand Volume II (1997), Amarin Printing and Publishing Public Co. Ltd., Bangkok
20. Shirwaikar A., Rajendran K., and Barik R. Effect of aqueous bark extract of Garuga pinnata Roxb. in streptozotocin-nicotinamide induced type-II diabetes mellitus. J Ethnopharmacol 107 (2006) 285-290
21. Peungvicha P., Thirawarapan S.S., Temsiririrkkul R., Watanabe H., Kumar Prasain J., and Kadota S. Hypoglycemic effect of the water extract of Piper sarmentosum in rats. J Ethnopharmacol 60 (1998) 27-32
22. Abdel-Zaher A.O., Salim S.Y., Assaf M.H., and Abdel-Hady R.H. Antidiabetic activity and toxicity of Zizyphus spina-christi leaves. J Ethnopharmacol 101 (2005) 129-138
23. Wilson T.H., and Wiseman G. The use of sacs of everted small intestine for the study of the transference of substances from the mucosal to the serosal surface. J Physiol 123 (1954) 116-125
24. Nagler R., Forrest W.J., and Spiro H.M. Effect of glucagon on transfer of glucose, utilizing everted sacs of small intestine. Am J Physiol 198 (1960) 1323-1325
25. Latha M., Pari L., Sitasawad S., and Bhonde R. Insulin-secretagogue activity and cytoprotective role of the traditional antidiabetic plant Scoparia dulcis (sweet broomweed). Life Sci 75 (2004) 2003-2014
26. Shewade Y.M., Umrani M., and Bhonde R.R. Large-scale isolation of islets by tissue culture of adult mouse pancreas. Transplant Proc 31 (1999) 1721-1723
27. Merglen A., Theander S., Rubi B., Chaffard G., Wollheim C.B., and Maechler P. Glucose sensitivity and metabolism-secretion coupling studied during two-year continuous culture in INS-1E insulinoma cells. Endocrinology 145 (2004) 667-678
28. Elsner M., Guldbakke B., Tiedge M., Munday R., and Lenzen S. Relative importance of transport and alkylation for pancreatic beta-cell toxicity of streptozotocin. Diabetologia 43 (2000) 1528-1533
29. Szkudelski T. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res 50 (2001) 537-546
30. Geng X., Li L., Bottino R., Balamurugan A.N., Bertera S., Densmore E., et al. Antidiabetic sulfonylurea stimulates insulin secretion independently of plasma membrane KATP channels. Am J Physiol Endocrinol Metab 293 (2007) E293-E301
31. Shigeto M., Katsura M., Matsuda M., Ohkuma S., and Kaku K. First phase of glucose-stimulated insulin secretion from MIN 6 cells does not always require extracellular calcium influx. J Pharmacol Sci 101 (2006) 293-302
32. Ligtenberg J.J., Venker C.E., Sluiter W.J., Reitsma W.D., and Van Haeften T.W. Effect of glibenclamide on insulin release at moderate and high blood glucose levels in normal man. Eur J Clin Invest 27 (1997) 685-689
33. Ortiz-Andrade R.R., Sánchez-Salgado J.C., Navarrete-Vázquez G., Webster S.P., Binnie M., García-Jiménez S., et al. Antidiabetic and toxicological evaluations of naringenin in normoglycaemic and NIDDM rat models and its implications on extra-pancreatic glucose regulation. Diabetes Obes Metab 10 (2008) 1097-1104
34. Zhou G., Myers R., Li Y., Chen Y., Shen X., Fenyk-Melody J., et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 108 (2001) 1167-1174
35. Peungvicha P., Thirawarapan S.S., and Watanabe H. Possible mechanism of hypoglycemic effect of 4-hydroxybenzoic acid, a constituent of Pandanus odorus root. Jpn J Pharmacol 78 (1998) 395-398
36. Sanford P.A., Smyth D.H., and Watling M. Sources of energy for transfer systems in the rat intestine. J Physiol Lond 179 (1965) 72
37. Tas S., Sarandol E., Ziyanok-Ayvalik S., Ocak N., Serdar Z., and Dirican M. Vanadyl sulfate treatment improves oxidative stress and increases serum paraoxonase activity in streptozotocin-induced diabetic rats. Nutr Res 26 (2006) 670-676
38. Ceriello A. The possible role of postprandial hyperglycaemia in the pathogenesis of diabetic complications. Diabetologia 46 (2003) M9-M16
39. Chiasson J.L., Josse R.G., Gomis R., Hanefeld M., Karasik A., Laakso M., et al. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 359 (2002) 2072-2077
40. Scheen A.J. Is there a role for alpha-glucosidase inhibitors in the prevention of type 2 diabetes mellitus?. Drugs 63 (2003) 933-951
41. Hollander P.A., Levy P., Fineman M.S., Maggs D.G., Shen L.Z., Strobel S.A., et al. Pramlintide as an adjunct to insulin therapy improves long-term glycemic and weight control in patients with type 2 diabetes: a 1-year randomized controlled trial. Diabetes Care 26 (2003) 784-790
42. Weyer C., Gottlieb A., Kim D.D., Lutz K., Schwartz S., Gutierrez M., et al. Pramlintide reduces postprandial glucose excursions when added to regular insulin or insulin lispro in subjects with type 1 diabetes: a dose-timing study. Diabetes Care 26 (2003) 3074-3079
43. Eidi A., Eidi M., and Sokhteh M. Effect of fenugreek (Trigonella foenum-graecum L) seeds on serum parameters in normal and streptozotocin-induced diabetic rats. Nutr Res 27 (2007) 728-733